Home About Press Employ Contact Spyglass Advanced Search
HHMI Logo
HHMI News
HHMI News
Scientists & Research
Scientists & Research
Janelia Farm
Janelia Farm
Grants & Fellowships
Grants & Fellowships
Resources
Resources
HHMI Bulletin
Current Issue Subscribe
Back Issues About the Bulletin
September '05
Features
divider
Cech
divider
UpFront
divider
Chronicle
divider
Science Education
divider

EXtreme Impactsmall arrow

divider

Undergrad Helps Find Possible West Nile Cure

divider

Not Your Ordinary 'Toonssmall arrow

divider

Medical and Dental Students Win HHMI Research Awardssmall arrow

divider

Boosting Science Education, One Step at a Timesmall arrow

divider

Modern-Day Bioethical Issues: The DVDsmall arrow

divider
International Science
divider

A Global Approach to
Global Problemssmall arrow


divider

Uncovering Genetic Combinationssmall arrow

divider
Up Close
divider

Protein Disposal:
Gumming Up the Workssmall arrow


divider
Perspectives
divider
Editor

Subscribe Free
Sign up now and receive the HHMI Bulletin by mail free.small arrow

CHRONICLE

PAGE 1 OF 2

SCIENCE EDUCATION:
Undergrad Helps Find Possible West Nile Cure
by Doug Main

Undergrad Helps Find Possible West Nile Cure

"At first, it was like a whole new world to me," says Christopher Doane, 21, of his work in Michael S. Diamond's lab.

Awarded an HHMI undergraduate fellowship after his freshman year at Washington University in St. Louis, Doane was assigned to generate monoclonal antibodies against a specific protein of the West Nile virus (WNV).

The goal sounded difficult, and even veteran researchers attest to the complexity of the process. Diamond, who researches infectious diseases at Washington University School of Medicine, taught Doane how to create special antibody-producing cells, called hybridomas, to combat WNV—a mosquito-borne pathogen that can afflict humans with anything from mild flu symptoms to brain swelling and occasionally even death.

Of his great grandfather, who helped found HHMI, Christopher Doane says, "I am just amazed a person could help so many people in his lifetime."

The laboratory process involves fusing tumor cells with the spleen cells of lab mice previously inoculated with WNV's E protein. If the fusion is done just right, the two cells create a hybridoma and secrete monoclonal antibodies capable of binding to the E protein, thereby neutralizing the virus. To increase the odds of success, a number of fusions are attempted at once in a multiwell plate; bright fluorescence within a well signals a successful binding.

During his first 5 months, Doane achieved little success. He kept at it into the next school year. Then, one day near Thanksgiving, his luck changed.

"The whole well plate lit up," says Doane. Preliminary results suggested he had generated 30 different hydridomas, each secreting antibody against WNV E protein. Doing further screening, Doane and his colleagues observed that one antibody in particular, named E16, had surprising binding ability--it neutralized 10 different strains of WNV, preventing the virus from infecting cells. Further testing showed that E16 prevented infected mice from dying, even when administered up to 5 days after exposure.

Photo: Bob Hower / Quadrant Photography

dividers
PAGE 1 OF 2
Continue small arrow
dividers
Download Story PDF
Requires Adobe Acrobat
Email This Story
Related Links

AT HHMI

bullet icon

History of HHMI

dividers
Back to Topto the top
HHMI Logo

Home | About HHMI | Press Room | Employment | Contact

© 2012 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | e-mail: webmaster@hhmi.org